Latest Resources
27 October 2010
Biosafety Protocol: Ten years on and lagging far behind
Mariam Mayet attended COP MOP 5 in Nagoya Japan. Indeed, she has been following the Biosafety Protocol discussions since 1999. In this brief, she argues that the Biosafety Protocol lags far behind the biosafety challenges faced by developing countries such as South Africa. She also expresses deep disappointment with the loss of a international civil […]
21 July 2010
Who is Biosafety South Africa
In this briefing, we present an overview of a new organisation called Biosafety South Africa. Biosafety South Africa was launched early this year, receives funding from the South African government through the Department of Science and Technology. Biosafety South Africa has no legislative mandate to influence GMO decision-making but appears set to carve its niche […]
14 May 2010
A good neighbour? South Africa forcing GM maize onto African markets and policy makers
Since the beginning of 2010, South Africa’s Executive Council responsible for GMO permit approvals has granted export permits for almost 300,000 Metric Tons (MT) of GM maize to be exported to Kenya, Mozambique, and Swaziland collectively, and 35,000 MT of GM soybean to Mozambique.1 Despite South Africa being Africa’s largest producer of maize, and a […]
12 April 2010
GM Sugarcane: A long way from commercialisation?
Despite the best part of a decade of research and field trials, genetically modified sugar cane in South Africa remains a long way from commercial cultivation. Numerous research projects are currently underway at a number of publicly and privately funded research bodies, most of which are concentrating on increased sucrose and biomass content. Late last […]
4 March 2010
The GM stacked gene revolution: A biosafety nightmare
Stacked GMOs are those containing more than one gene genetically engineered into a crop plant. A controversial stacked GMO, Smarstax containing 8 such genetically engineered genes, was commercially approved in the US, Canada, Japan and South Korea during 2009. Stacked gene varieties are highly complex, posing new biosafety risks that outpace the capacity of regulatory […]
13 January 2010
Africa’s Green Revolution Drought Tolerant Maize Scam
Prediction of exacerbated drought in Africa due to climate change is apparently the driving force behind the establishment of the Water Efficient Maize for Africa (WEMA) initiative, another prong of the so-called ‘New Green Revolution for Africa’ WEMA seeks to develop drought tolerant maize varieties through a program which is being presented as a panacea […]
11 December 2009
Africa’s Granary Plundered Privatisation of Tanzanian Sorghum Protected by the Seed Treaty
A gene recently isolated from a Tanzanian farmers’ variety of sorghum may yield tremendous pros for multinational companies and government researchers in the United States and Brazil. Called SbMATE, it is not only useful in sorghum; but also may be used in other crops, including genetically engineered (GE) maize, wheat, and rice as well as […]
28 September 2009
Patents, Climate Change and African Agriculture: Dire Predictions
Uncertainty and apprehension often afford opportunity to the cunning. This is certainly the case with climate change. The multinational seed and agrochemical industry see climate change as a means by which to further penetrate African agricultural markets by rhetorically positioning itself, even if implausibly, as having the solution to widespread climate concerns. Their so-called “final […]
31 August 2009
Genes from Africa: the colonisation of African DNA
“You people. We thought you folks had taken everything you could. You took our land, you took our homes. You stole our pottery and our songs and our blankets and our designs. You took our language and, in some places, you even took our children. You snatched at our religion and at our women. You […]
10 August 2009
Critical overview of South Africa’s Bioprospecting laws
In this booklet, we provide an overview of the core provisions of the legislative framework governing bioprospecting, access and benefit sharing in South Africa. In particular, we highlight the lack of opportunity for public participation by civil society in the bioprospecting permitting process, problems with accessing information, issues relating to the restricted appeal process, and […]